314
Views
13
CrossRef citations to date
0
Altmetric
Letter to the Editor

Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves’ Ophthalmopathy, a Report of Three Cases

ORCID Icon, &
Pages 281-284 | Received 17 Jun 2018, Accepted 05 Nov 2018, Published online: 20 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shyang-Rong Shih, Shu-Lang Liao, Chih-Wei Shih, Yi-Hsuan Wei, Ting-Xuan Lu, Chien-Hsiang Chou, Er-Yen Yen, Yi-Cheng Chang, Chia-Chi Lin, Yu-Chiao Chi, Wei-Shiung Yang & Feng-Chiao Tsai. (2021) Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy. Ocular Immunology and Inflammation 29:1, pages 193-202.
Read now

Articles from other publishers (12)

Clara J. MenLinus AmarikwaBrandon PhamConnie SearsKevin ClaussBradford W. LeeWendy W. LeeJoshua PasolShoaib UgradarRoman ShinderKimberly CockerhamSara WesterRaymond DouglasAndrea L. Kossler. (2023) Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease. Ophthalmic Plastic & Reconstructive Surgery.
Crossref
Naiara F. Xavier, Daniela Tavares Lucena & Antonio A. V. Cruz. (2023) Monoclonal Antibodies for the Treatment of Graves Orbitopathy: Precision Medicine?. Ophthalmic Plastic & Reconstructive Surgery 39:4, pages 307-315.
Crossref
M. Pelewicz-Sowa & P. Miśkiewicz. (2023) Dysthyroid optic neuropathy: emerging treatment strategies. Journal of Endocrinological Investigation 46:7, pages 1305-1316.
Crossref
Xuejiao Cui, Futao Wang & Cong Liu. (2023) A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy. Frontiers in Immunology 14.
Crossref
Tracy J. Lu, Linus Amarikwa, Connie M. Sears & Andrea L. Kossler. (2022) Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy. Current Neurology and Neuroscience Reports 22:6, pages 313-325.
Crossref
A. Yan Lun, M. Le Bras, E. Scharbarg, P. Morcel, S. Hadjadj, P. Lebranchu & D. Drui. (2022) L’orbitopathie basedowienne: diagnostic, épidémiologie et principes de traitement. La Revue de Médecine Interne 43:4, pages 242-251.
Crossref
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Stefania Camastra, Mario Miccoli, Gabriella Cavallini, Salvatore Benvenga & Alessandro Antonelli. (2021) Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy. Frontiers in Endocrinology 12.
Crossref
José V. Pérez-Moreiras, María Varela-Agra, M. Consuelo Prada-Sánchez & Guillermo Prada-Ramallal. (2021) Steroid-Resistant Graves’ Orbitopathy Treated with Tocilizumab in Real-World Clinical Practice: A 9-Year Single-Center Experience. Journal of Clinical Medicine 10:4, pages 706.
Crossref
Aysel Mehmet, Eirini Kanella Panagiotopoulou, Aristeidis Konstantinidis, Charalampos Papagoras, Panagiotis Skendros, Doukas Dardabounis, Athanasia Maria Mikropoulou & Georgios Labiris. (2021) Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab. Acta Medica (Hradec Kralove, Czech Republic) 64:1, pages 64-69.
Crossref
Min Joung Lee, Bronwyn E. Hamilton, David Pettersson, Kimberly Ogle, Jennifer Murdock, Roger A. Dailey, John D. Ng, Eric A. Steele, Rohan Verma, Stephen R. Planck, Tammy M. Martin, Dongseok Choi & James T. Rosenbaum. (2020) Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity. Scientific Reports 10:1.
Crossref
Lara Sánchez-Bilbao, David Martínez-López, Marcelino Revenga, Ángel López-Vázquez, Elia Valls-Pascual, Belén Atienza-Mateo, Beatriz Valls-Espinosa, Olga Maiz-Alonso, Ana Blanco, Ignacio Torre-Salaberri, Verónica Rodríguez-Méndez, Ángel García-Aparicio, Raúl Veroz-González, Vega Jovaní, Diana Peiteado, Margarita Sánchez-Orgaz, Eva Tomero, Francisco J. Toyos-Sáenz de Miera, Valvanera Pinillos, Elena Aurrecoechea, Ángel Mora, Arantxa Conesa, Manuel Fernández-Prada, Juan A. Troyano, Vanesa Calvo-Río, Rosalía Demetrio-Pablo, Íñigo González-Mazón, José L. Hernández, Santos Castañeda, Miguel Á. González-Gay & Ricardo Blanco. (2020) Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients. Journal of Clinical Medicine 9:9, pages 2816.
Crossref
Alan Chun Hong Lee & George J. Kahaly. (2020) Novel Approaches for Immunosuppression in Graves’ Hyperthyroidism and Associated Orbitopathy. European Thyroid Journal 9:Suppl. 1, pages 17-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.